Interiglin 20mg Injection
By Interiglin
Rx
10ml Injection in a Vial

Composition
Eptifibatide(20mg)

Manufacturer - MSD Pharmaceuticals Pvt Ltd
Platina, 8th Floor, C.59, G Block, Bandra Kurla Complex, Bandra (East) , Mumbai - 400098,

Expires on or after
September, 2025

liver
Caution should be exercised when considering the use of Interiglin 20mg Injection in patients with liver disease. It is advisable to consult with your doctor before using this injection, especially if you have a history of liver problems. It is important to note that the use of Interiglin 20mg Injection is not recommended in individuals with severe liver disease. Your healthcare provider can assess your specific situation and determine the best course of action regarding the injection and its impact on your liver health.

kidney
Interiglin 20mg Injection requires caution in patients with kidney disease. Dosage adjustment may be necessary, and it is not advised for those with severe kidney issues. Please consult your doctor before using this medication.

alcohol
Consult your doctor when consuming alcohol with Interiglin 20mg Injection.

driving
As Interiglin 20mg Injection is designed for hospitalized patients, driving-related safety advice is not applicable. It is advisable to consult a doctor, especially if experiencing symptoms that may affect focus and reaction time.

pregnancy
Interiglin 20mg Injection is usually safe in pregnancy. Animal tests show minimal risk to the baby, but human studies are limited.

breastfeeding
Interiglin 20mg Injection needs caution while breastfeeding. It is advised to pause breastfeeding until the mother's treatment is finished and the drug is cleared from her body.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | - |
Action Class | - |
₹3000
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024